醋酸氟轻松
醋酸氟轻松结构式
|
常用名 | 醋酸氟轻松 | 英文名 | FLUOCINONIDE |
|---|---|---|---|---|
| CAS号 | 356-12-7 | 分子量 | 494.525 | |
| 密度 | 1.3±0.1 g/cm3 | 沸点 | 591.1±50.0 °C at 760 mmHg | |
| 分子式 | C26H32F2O7 | 熔点 | 309ºC | |
| MSDS | 中文版 美版 | 闪点 | 311.3±30.1 °C | |
| 符号 |
GHS06, GHS08 |
信号词 | Danger |
|
Effects of a novel formulation of fluocinonide 0.1% cream on skin barrier function in atopic dermatitis.
Journal. of. Drugs in. Dermatology. 10(2) , 171-6, (2011) To determine the effect a novel formulation of fluocinonide cream on skin barrier function in subjects with atopic dermatitis.The authors performed an open-label, investigator-blinded, side-by-side, controlled trial examining skin barrier function before and ... |
|
|
Urticarial hypersensitivity reaction caused by temozolomide.
Journal. of. Drugs in. Dermatology. 9(9) , 1142-4, (2010) Temozolomide is an oral alkylating agent approved for the treatment of glioblastoma and anaplastic astrocytoma, and is currently under clinical investigation for the treatment of brain metastases from a variety of cancers. Temozolomide is well tolerated, and ... |
|
|
In vivo determination of the skin atrophy potential of the super-high-potency topical corticosteroid fluocinonide 0.1% cream compared with clobetasol propionate 0.05% cream and foam, and a vehicle.
Journal. of. Drugs in. Dermatology. 7(1) , 28-32, (2008) Prolonged topical corticosteroid use is often associated with atrophic skin changes. This trial compared signs of skin atrophy related to 3 super-high-potency corticosteroids: fluocinonide 0.1% cream, clobetasol propionate 0.05% cream, and 0.05% foam.The test... |
|
|
The efficacy of three class I topical synthetic corticosteroids, fluocinonide 0.1% cream, clobetasol 0.05% cream and halobetasol 0.05% cream: a Scholtz-Dumas bioassay comparison.
Journal. of. Drugs in. Dermatology. 8(8) , 751-5, (2009) This study compared the efficacy of a novel, topical class I synthetic, 0.10% fluocinonide corticosteroid with two other class I corticosteroids and placebo for the treatment of plaque psoriasis.A 0.5 gram dose of fluocinonide 0.1% cream, clobetasol propionat... |
|
|
Reticulated phototoxic eruption in a patient on long-term diltiazem therapy.
Journal. of. Drugs in. Dermatology. 7(8) , 792-3, (2008) Diltiazem hydrochloride is a commonly prescribed medication in the treatment of cardiovascular disease. A case of diltiazem-induced hyperpigmentation in a patient after significant sun exposure is reported. The morphological appearance was reticulated and sla... |
|
|
Improvement in treatment adherence with a 3-day course of fluocinonide cream 0.1% for atopic dermatitis.
Cutis. 86(4) , 208-13, (2010) Variations in adherence may cause variations in treatment outcomes with topical corticosteroid therapy for atopic dermatitis. An intensive short course of outpatient treatment may promote good adherence and provide a high level of efficacy. The purpose of thi... |
|
|
A single-center, double-blind, randomized trial of the atrophogenic effects of fluocinonide cream 0.1% versus clobetasol propionate cream 0.05% in participants with corticosteroid-responsive dermatoses.
Cutis. 81(6) , 517-9, (2008) To compare the atrophogenic effects of fluocinonide cream 0.1% versus clobetasol propionate cream 0.05%, 20 participants with corticosteroid-responsive dermatoses were randomly assigned to receive fluocinonide cream 0.1% on one arm and clobetasol propionate c... |
|
|
Rapid cutaneous dissemination of persistently agminated lymphomatoid papulosis in a 9-year-old boy.
Arch. Dermatol. 147(11) , 1340-2, (2011)
|
|
|
Localized acral pityriasis lichenoides chronica: report of a case.
J. Dermatol. 38(8) , 832-4, (2011)
|
|
|
Erythematous papules and pustules on the scalp.
Pediatr. Dermatol. 26(2) , 195-6, (2009)
|